Key result
Ang-1 adenoviral vector administration upregulated intercellular junction proteins and promoted the integrity of neovascularization in the subcutaneous Matrigel of type 1 diabetic rats.
Why the study?
This study aimed to investigate the effects of Ang-1 on neovascularization of diabetic organs using a subcutaneous Matrigel angiogenesis model established in type 1 diabetic rats.
Does Ang-1 gene therapy improve the integrity of neovascularization in a subcutaneous Matrigel model in type 1 diabetic rats?
Does Ang-1 gene therapy improve the integrity of neovascularization in a subcutaneous Matrigel model in type 1 diabetic rats?
Ang-1 gene therapy promotes the integrity of neovascularization and reduces pathological angiogenesis in a diabetic rat model.
May enhance neovascularization in diabetic rat models; leaves open human translation and clinical relevance.
OBJECTIVE: This study aimed to investigate the effects of Ang-1 on neovascularization of diabetic organs by subcutaneous Matrigel angiogenesis model, established in type 1 diabetic rats. METHODS: Ang-1 adenoviral vector was constructed. The rat model was established by STZ and divided into four group. The Matrigel was inserted subcutaneously into the abdominal cavity of rats at 8 weeks, the treatment group was injected with Ang-1 adenovirus vector via tail vein, and the rats were sacrificed at 10 weeks. Neovascularization of Matrigel was observed with transmission electron microscopy. The marker of vascular endothelial cell and pericyte were detected by immunofluorescence. Immunohistochemical detection of the neovascular endothelial junction protein was performed. RT-PCR was used to determine protein expression of neovascular in Matrigel. RESULTS: Vascular cavity-like structure could be seen in subcutaneous Matrigel of diabetic rats, and the cavity was filled with a lot of red blood cells. Transmission electron microscopy showed that neovascular endothelial structure of the Matrigel was incomplete, while the Ang-1 treatment group had more vascular cavity-like structures, intact vascular endothelial structure, and reduced inflammatory cell infiltration in Matrigel. Additionally, the integrity of vascularization improved, and the marker of pericyte and the cell tight junctions protein was upregulated in Ang-1 treatment group. CONCLUSION: Hyperglycemia could induce pathological angiogenesis in subcutaneous Matrigel of diabetic rats, and Ang-1 could upregulate the expression of intercellular junction protein in subcutaneous Matrigel of diabetic rats and promote the integrity of neovascularization in the subcutaneous Matrigel of diabetic rats.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied Type 1 diabetes (animal model). Ang-1 adenoviral vector vs. Control (no Ang-1 treatment) was evaluated on Integrity of neovascularization and expression of intercellular junction proteins. Ang-1 adenoviral vector administration upregulated intercellular junction proteins and promoted the integrity of neovascularization in the subcutaneous Matrigel of type 1 diabetic rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: